Statements
ABPM and HBPM Keeping Patients Safe
BIHS Statement on infection control in the use of BP monitoring equipment. January 2021
BIHS Statement published by the Journal of Human Hypertension January 2021
BIHS Statement published by the Journal of Human Hypertension November 2020
Measurement of Blood Pressure in the Leg
BIHS Statement published by the Journal of Human Hypertension April 2020
BIHS Statement on ACE/ARB and Covid-19
Measurement of blood pressure in people with atrial fibrillation
BIHS Statement published by the Journal of Human Hypertension October 2019
The Importance of a Valid Assessment of Salt Intake in Individuals and Populations
BIHS Statement published by the Journal of Human Hypertension April 2019
Oscillometric Measurement of Blood Pressure: A Simplified Explanation
BIHS Technical Note published by the Journal of Human Hypertension April 2019
BIHS Statement on Diagnosis of Hypertension in Obese Patients November 2017
Guidance on BP monitor cuffs for use in diagnosing hypertension in obese patients.
BIHS Statement on Aspirin October 2017
Response to recent publicity and debate resulting from reports questioning the benefits of aspirin use in those with no history of prior CVD, including those with diabetes, particularly in the context of the known increase in risk of gastrointestinal bleeding.
The Joint UK Societies 2014 Consensus Statement on Renal Denervation
The Consensus Statement was published in Heart in November 2014. The above links to the online open-access article.
BHS Endorses the Use of Single Pill Combination Treatments in Hypertension August 2013
It is thought that between a third and a half of all medicines prescribed for long-term conditions are not taken as recommended. ‘Simplifying the dosing regimen’ is one way of improving patient adherence as suggested by the NICE medicines adherence guidelines.